Therefore, it may serves as a novel target for NSCLC radiotherapy,486,487 Additionally, lncRNA SBF2-AS1 and lncRNA FAM201A also promote radiotherapy resistance in NSCLC by reducing cellular apoptosis488 (Fig. 4). Here, SBF2 is linked to non-small cell lung carcinoma.